The Relationship Between Obesity and Serum 1,25-dihydroxy Vitamin D Concentrations in Healthy Adults
Overview
Authors
Affiliations
Several previous reports of small cohorts have found significantly higher serum 1,25-dihydroxy vitamin D (1,25-vit D) in obese compared with nonobese whites. Based on these reports and on recent in vitro studies of adipocytes which suggest that administration of 1,25-vit D can stimulate lipogenesis and inhibit lipolysis, some investigators have proposed that high 1,25-vit D may play a role in promoting or maintaining adipocyte triglyceride stores in obese adults. To test the hypothesis that obesity is commonly associated with increased 1,25-vit D, we examined the relationships between calciotropic hormones and body adiposity in a large cohort of healthy adults. Serum intact PTH, 25-hydroxy vitamin D, and 1,25-vit D were measured in the postabsorptive state in 302 healthy adults who were Caucasian (n = 190; 71% female), African-American (n = 84; 89% female), and of other race/ethnicity (n = 28; 61% female). Results from the 154 obese subjects [body mass index (BMI) 37.3 +/- 5.8 kg/m(2); range, 30.1-58.2 kg/m(2)] were compared with those from 148 nonobese (BMI 25.6 +/- 2.9 kg/m(2); range, 18.0-29.9 kg/m(2)) age-, race-, and sex-matched participants. Body composition was measured by dual energy x-ray absorptiometry. Serum intact PTH was positively correlated with both BMI (r = 0.42; P < 0.0001) and body fat mass (r = 0.37; P < 0.0001). Serum 25-hydroxy vitamin D was negatively correlated with BMI (r = -0.4; P < 0.0001) and body fat mass (r = -0.41; P < 0.0001). Serum 1,25-vit D was also negatively correlated with BMI (r = -0.26; P < 0.0001) and body fat mass (r = -0.25; P = 0.0001). Serum 1,25-vit D was significantly lower in obese than nonobese subjects (105.7 +/- 41.1 vs. 124.8 +/- 36.7 pmol/liter; P < 0.0001) in both Caucasian and African-American adults. We conclude that, because 1,25-vit D concentrations fall with increasing adiposity, it appears unlikely that elevation in 1,25-vit D is an important hormonal mechanism causing or maintaining obesity in adults.
Ashraf H, Maghbouli N, Abolhasani M, Zandi N, Nematizadeh M, Omidi N J Health Popul Nutr. 2024; 43(1):206.
PMID: 39623455 PMC: 11613886. DOI: 10.1186/s41043-024-00668-3.
Provvisiero D, Negri M, Amatrudo F, Patalano R, Monto T, de Angelis C Int J Obes (Lond). 2024; 48(12):1793-1802.
PMID: 39256615 PMC: 11584397. DOI: 10.1038/s41366-024-01629-w.
Bibliometric analysis of vitamin D and obesity research over the period 2000 to 2023.
Song X, Qin S, Chen S, Zhang C, Lin L, Song Z Front Pharmacol. 2024; 15:1445061.
PMID: 39092232 PMC: 11291317. DOI: 10.3389/fphar.2024.1445061.
High-Volume Liposuction in Lipedema Patients: Effects on Serum Vitamin D.
Flores T, Kerschbaumer C, Jaklin F, Glisic C, Sabitzer H, Nedomansky J J Clin Med. 2024; 13(10).
PMID: 38792387 PMC: 11121803. DOI: 10.3390/jcm13102846.
Qu Y, Song Y, Sun R, Ma Y, Zhang Y Physiol Res. 2024; 73(2):265-271.
PMID: 38710056 PMC: 11081187.